ELRIG Networking events are a great way to get to know other like-minded individuals in your local area. Since the end of 2016, we have been running regular networking meetings in various locations throughout the UK.
ELRIG is a not for profit organisation, whose mission is to provide outstanding, leading edge knowledge to the life sciences community on an open access basis which is free for delegates to attend. ELRIG networking events are an extension of this ethos.
These meetings are usually held in the evening, and involve informal presentations by guest speakers from academia and industry which encourage and foster collaboration and opportunities between local research groups. The presentations are always followed by a food and drinks reception to facilitate further networking.
We believe that through enhanced collaboration between scientists from academia, pharma / biotech and the technology industry, we can offer the opportunity to create a truly unique and open forum, engaging researchers in a beneficial manner and within a local geographical environment.
ELRIG Networking event: Next-generation CRISPR technologies – Download the Agenda
Tuesday 26th November 2019: 5.30pm – 8.00pm (Registration from 5pm)
The Francis Crick Institute
1 Midland Road, London
NW1 1AT
United Kingdom
We return to the Francis Crick Institute for this free-to-attend ELRIG networking event. CRISPR gene editing technologies have revolutionised our ability to manipulate, image and annotate specific nucleotide sequences within live cells and organisms. Uses range from fundamental scientific research to translational medicine.
Our networking events, follow the model of short, informal presentations by guest speakers from academia and industry which encourage and foster collaboration and opportunities between local research groups. The presentations are always followed by a food and drinks reception to facilitate further networking.
We believe that through enhanced collaboration between scientists from academia, pharma / biotech and the technology industry, we can offer the opportunity to create a truly unique and open forum, engaging researchers in a beneficial manner and within a local geographical environment.
To learn more about novel CRISPR applications and innovation within this area come and join us at this ELRIG networking meeting.
Confirmed Speakers
Manolis Gialitakis (Horizon Discovery)
Pooled and arrayed CRISPRko screens in primary human immune cells
Lorea Blazquez (The Francis Crick Institute)
Beyond CRISPR-Cas9: Transcriptome engineering with RNA-targeting CRISPR-Cas13 systems
Waseem Qasim (UCL)
CRISPR edited therapeutic T cells
ELRIG Networking event: Artificial Intelligence in Drug Discovery
Thursday 5th December 2019: 5.30pm – 8.00pm (Registration from 5pm)
Alderley Park Conference Centre
Alderley Park
Alderley Edge
Macclesfield
SK10 4TG
This event has now passed. Please check back soon for further ELRIG networking events in this area.
ELRIG Networking Event in association with Biocity, Scotland: How ArtificiaI Intelligence & Machine Learning will change the future of drug discovery and drug development.
Wednesday 15th May 2019
Time: 10am – 4pm (registration from 9.30am)
Biocity, Scotland
Bo’Ness Rd, Newhouse
Chapelhall
Motherwell
ML1 5UH
Travel Directions
Where is Artificial Intelligence and Machine Learning leading us, what does the future really hold for these technologies and how they will change our Drug Discovery and development paradigms? AI and Big Data analysis have started making progress but how far can AI & ML really improve lab data analysis and fields such as cellular imaging, sequencing, chemistry, biology, biological ontology and the drug discovery process in general?
Join us for this ELRIG/ MediCity meeting to hear speakers from across academia, biotech and the pharma industry offering their unique insights.
Confirmed Speakers:
Angelo Pugliese (CRUK Beatson Institute)
AI/ML in drug discovery: “How To” and beyond
Use of DigitalGlassware™ to improve productivity and discovery in research and process chemistry laboratories
Neil Carragher (University of Edinburgh)
Multiparametric high content imaging: An enabling technology for emerging A.I. applications in drug discovery
James Hopgood (University of Edinburgh)
The event is free to attend and will be followed by the opportunity to network over food and drinks.
With thanks to our host and sponsors:
This event has now passed. Please check back soon for further ELRIG networking events in this area.
ELRIG Networking Event: Artificial Intelligence in drug discovery (Download the event flyer)
Wednesday 20th March 2019
5:30-8:00pm (registration from 5:00pm)
Cancer Research UK Cambridge Institute
University of Cambridge
Robinson Way
Cambridge
CB2 0RE
Artificial Intelligence and machine learning are promised to transform every aspect of modern research, from the bench to the bedside. What is the truth behind these revolutionary claims and how far will AI impact on daily scientific exploration?
Join us for this ELRIG Networking meeting where we will explore how these technologies are already being used across different disciplines of drug discovery research. We’ve speakers from across academia, biotech and industry who will offer their unique insights into where AI will lead us and what the future reality holds.
Confirmed Speakers
Andreas Bender (Group leader at the Centre for Molecular Informatics, Department of Chemistry, University of Cambridge)
‘Algorithms in Drug Discovery – From Hype to Reality’
Adam Corrigan (Senior Research Scientists, Discovery Sciences IMED, AstraZeneca)
‘Revolutionising Cellular Screening with Artificial Intelligence’
Andrea Taddei (Mechanistic Area Lead, BenevolentAI)
‘Artificial Intelligence – From Data to Drugs’
Following the presentations, there will be a complimentary food and drinks reception, giving further networking opportunities. We look forward to welcoming you to Cambridge on the 20th of March.
With thanks to our event host & sponsors:
ELRIG Networking Event in partnership with Sygnature Discovery: The evolution of Drug Discovery: an anti-inflammatory perspective.
Thursday 13th June 2019
5:30pm – 8:00pm (registration from 5:00pm)
BioCity, Nottingham
Pennyfoot Street
Nottingham
NG1 1GF
Targeting inflammatory processes has proved highly effective in treating arthritis, chronic pain, respiratory and cardiovascular disease. Steroids, ibuprofen, aspirin, and other NSAIDs are some of the world’s most widely used drugs. But where to next and what more can be achieved through our deeper understanding of the biology of inflammation and the immune system?
Confirmed Speakers
John Unitt (Sygnature Discovery)
A Journey through Anti-Inflammatory Drug Discovery
Lucy Fairclough (University of Nottingham)
Inflammation of the Airways: Asthma and COPD
Julie Rayes (University of Birmingham)
Platelets in inflammation: biomarker and drug target
Download the agenda
Join us for this ELRIG networking event to hear speakers from industry, biotech and academia discuss the latest developments in the field, and share perspectives on the next wave of anti-inflammatory drugs.
With thanks to our host and sponsors:
ELRIG Networking event: New Targets & Modalities in Fibrosis
Wednesday 18th September 2019: Time 5.30pm – 8.30pm (registration from 5pm)
Vertex Pharmaceuticals
86-88 Jubilee Avenue
Milton Park
Abingdon
Oxford
OX14 4RW
What are researchers doing to support patients with fibrosis? What novel targets and modalities are being explored and how are we testing them? To find out more about the complex biology of fibrosis and how collaborative working is supporting innovation in this area come join us at this ELRIG meeting.
You will hear speakers from across academia, biotech and the pharma industry offering their unique insights. The event is free to attend and will be followed by the opportunity to network over food and drinks.
Confirmed Speakers
Professor Jagdeep Nanchahal (Kennedy institute)
“Localized fibrosis in humans – target identification to validation in clinical trials”
Professor Nicolas Barnes (Celentyx)
“Regulation of the fibrotic response by serotonergic and purinergic pathways”
Dr Breda Twomey (UCB)
“Human fibrosis in vitro model systems that can be applied to drug discovery”